Laura Vidal

684 total citations
23 papers, 465 citations indexed

About

Laura Vidal is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Clinical Psychology. According to data from OpenAlex, Laura Vidal has authored 23 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Pediatrics, Perinatology and Child Health and 4 papers in Clinical Psychology. Recurrent topics in Laura Vidal's work include Prenatal Substance Exposure Effects (3 papers), Ovarian cancer diagnosis and treatment (3 papers) and Neuroscience of respiration and sleep (3 papers). Laura Vidal is often cited by papers focused on Prenatal Substance Exposure Effects (3 papers), Ovarian cancer diagnosis and treatment (3 papers) and Neuroscience of respiration and sleep (3 papers). Laura Vidal collaborates with scholars based in Spain, United States and United Kingdom. Laura Vidal's co-authors include Johann S. de Bono, Alison Reid, Heather Shaw, Alan Melcher, Lynette P. Steele, Fiona Errington‐Mais, Robin Prestwich, Hardev Pandha, Kevin J. Harrington and Matt Coffey and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Laura Vidal

22 papers receiving 453 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura Vidal Spain 10 231 135 133 79 78 23 465
Snehal M. Bhoola United States 11 226 1.0× 297 2.2× 277 2.1× 92 1.2× 37 0.5× 19 674
Josu Sola Spain 7 380 1.6× 140 1.0× 155 1.2× 259 3.3× 82 1.1× 12 705
Louise Hanna United Kingdom 12 211 0.9× 142 1.1× 126 0.9× 40 0.5× 63 0.8× 26 538
Xuejun Xu China 8 147 0.6× 130 1.0× 27 0.2× 36 0.5× 84 1.1× 12 506
Yang Cao China 19 638 2.8× 277 2.1× 166 1.2× 267 3.4× 54 0.7× 79 1.1k
Ludi Yang China 14 243 1.1× 339 2.5× 49 0.4× 80 1.0× 63 0.8× 40 636
Kimberly Jackson United States 13 65 0.3× 214 1.6× 167 1.3× 92 1.2× 41 0.5× 25 603
Nahid Nafissi Iran 14 151 0.7× 174 1.3× 48 0.4× 32 0.4× 95 1.2× 64 526
J. Palou-Redorta Spain 12 307 1.3× 347 2.6× 19 0.1× 116 1.5× 206 2.6× 21 1.8k
Judy Poore United States 9 154 0.7× 193 1.4× 48 0.4× 106 1.3× 35 0.4× 9 537

Countries citing papers authored by Laura Vidal

Since Specialization
Citations

This map shows the geographic impact of Laura Vidal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Vidal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Vidal more than expected).

Fields of papers citing papers by Laura Vidal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Vidal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Vidal. The network helps show where Laura Vidal may publish in the future.

Co-authorship network of co-authors of Laura Vidal

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Vidal. A scholar is included among the top collaborators of Laura Vidal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Vidal. Laura Vidal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mankan, Arun K., et al.. (2023). Intracellular DNA sensing by neutrophils and amplification of the innate immune response. Frontiers in Immunology. 14. 1208137–1208137. 5 indexed citations
2.
Vidal, Raquel, Laura Vidal, Françesc Solé, et al.. (2023). Dog-Assisted Therapy vs Relaxation for Children and Adolescents with Fetal Alcohol Spectrum Disorder: A Randomized Controlled Study. Journal of Autism and Developmental Disorders. 54(8). 3133–3141. 3 indexed citations
3.
Mankan, Arun K., Ángela Quintana, Sarabjot Pabla, et al.. (2023). Mechanisms of immune modulation in the tumor microenvironment and implications for targeted therapy. Frontiers in Oncology. 13. 1200646–1200646. 35 indexed citations
4.
Heras, Begoña de las, et al.. (2022). Role of decentralized clinical trials in cancer drug development: Results from a survey of oncologists and patients. Digital Health. 8. 2282130103–2282130103. 15 indexed citations
5.
Heras, Begoña de las, Lesley Reeve, Stephen Flach, et al.. (2021). Healthy volunteers in first‐in‐human oncology drug development for small molecules. British Journal of Clinical Pharmacology. 88(4). 1773–1784. 9 indexed citations
6.
Vidal, Raquel, et al.. (2021). Terapia Asistida con Perros en niños y adolescentes con Trastorno del Espectro Alcohólico Fetal. SHILAP Revista de lepidopterología.
7.
Vidal, Laura, et al.. (2021). New Limits of the Neoliberalism: Society and Market. Journal of Economic Issues. 55(2). 432–438. 3 indexed citations
8.
Vidal, Raquel, et al.. (2020). Dog-Assisted Therapy for Children and Adolescents With Fetal Alcohol Spectrum Disorders a Randomized Controlled Pilot Study. Frontiers in Psychology. 11. 1080–1080. 6 indexed citations
9.
Barca, Laura Varela, et al.. (2020). Estimación de la mortalidad quirúrgica de la endocarditis infecciosa: comparación de las diferentes escalas específicas de cálculo de riesgo. SHILAP Revista de lepidopterología. 27(3). 93–99. 1 indexed citations
10.
Mayoral, María, Aranzazu Fernández-Martínez, Laura Vidal, et al.. (2016). Prognostic value of 18 F-FDG PET/CT volumetric parameters in recurrent epithelial ovarian cancer. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition). 35(2). 88–95. 3 indexed citations
11.
Riu-Viladoms, Gisela, et al.. (2016). Implementation of a pharmaceutical care programme for patients receiving new molecular-targeted agents in a clinical trial unit. European Journal of Cancer Care. 27(1). e12447–e12447. 6 indexed citations
12.
García, Yolanda García, Ana De Juan, César Mendiola, et al.. (2015). Phase II randomized trial of neoadjuvant (NA) chemotherapy (CT) with or without bevacizumab (Bev) in advanced epithelial ovarian cancer (EOC) (GEICO 1205/NOVA TRIAL).. Journal of Clinical Oncology. 33(15_suppl). 5531–5531. 10 indexed citations
13.
14.
Pino, Marta del, Pere Fusté, Jaume Pahisa, et al.. (2013). Laparoscopic Lymphadenectomy in Advanced Cervical Cancer. International Journal of Gynecological Cancer. 23(9). 1675–1683. 24 indexed citations
15.
Errington‐Mais, Fiona, Lynette P. Steele, Robin Prestwich, et al.. (2008). Reovirus Activates Human Dendritic Cells to Promote Innate Antitumor Immunity. The Journal of Immunology. 180(9). 6018–6026. 150 indexed citations
16.
Tourneau, Christophe Le, Laura Vidal, & Lillian L. Siu. (2008). Progress and challenges in the identification of biomarkers for EGFR and VEGFR targeting anticancer agents. Drug Resistance Updates. 11(3). 99–109. 24 indexed citations
17.
Reid, Alison, Laura Vidal, Heather Shaw, & Johann S. de Bono. (2007). Dual inhibition of ErbB1 (EGFR/HER1) and ErbB2 (HER2/neu). European Journal of Cancer. 43(3). 481–489. 126 indexed citations
18.
Gelabert, A, et al.. (2005). Esteatohepatitis no alcohólica asociada a hiperplasia estromal ovárica. Gastroenterología y Hepatología. 28(7). 375–377. 2 indexed citations
19.
Vidal, Laura, Gerhardt Attard, Stan B. Kaye, & Johann S. de Bono. (2004). Reversing Resistance to Targeted Therapy. Journal of Chemotherapy. 16(sup4). 7–12. 11 indexed citations
20.
Bosch, R.J., et al.. (2000). Angiosarcoma arising on rhinophyma.. PubMed. 10(7). 555–8. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Snehal M. Bhoola Breakdown of academic impact, for papers by Josu Sola Breakdown of academic impact, for papers by Louise Hanna Breakdown of academic impact, for papers by Xuejun Xu Breakdown of academic impact, for papers by Yang Cao Breakdown of academic impact, for papers by Ludi Yang Breakdown of academic impact, for papers by Kimberly Jackson Breakdown of academic impact, for papers by Nahid Nafissi Breakdown of academic impact, for papers by J. Palou-Redorta Breakdown of academic impact, for papers by Judy Poore
Rankless by CCL
2026